マルチプレックス・バイオマーカー・イメージングの世界市場レポート 2025年

マルチプレックス・バイオマーカー・イメージングの市場規模は今後数年で急成長が見込まれます。2029年にはCAGR10.8％で8億2,000万米ドルに成長します。予測期間における成長の背景には、個別化医療の重視、研究開発活動の活発化、臨床試験の増加、創薬におけるハイスループットスクリーニング法の必要性、支持的な規制の枠組みやガイドラインなどがあります。予測期間における主な動向には、技術的進歩、画像技術の革新、デジタル病理学の進歩、データ分析および画像ソフトウェアの開発、AIおよび機械学習と画像技術の統合などがあります。

慢性疾患の有病率の増加は、今後数年間のマルチプレックス・バイオマーカー・イメージング市場の成長を促進すると予想されます。慢性疾患は、長期にわたって持続または再発する不朽の健康状態であり、多くの場合、複雑な起源、複数の危険因子、および長期にわたる潜伏期間を伴う。慢性疾患の有病率の上昇は、人口の急速な高齢化、疾患検出方法の改善、疾患治療と管理の向上、ライフスタイルや環境リスク要因の変化など、さまざまな要因に起因しています。マルチプレックス・バイオマーカー・イメージングは、病気の進行や治療に対する反応を包括的に分析し、特徴づけることで、慢性疾患の管理に重要な役割を果たしています。例えば、米国国立衛生研究所（NIH）が2023年1月に発表した報告書では、少なくとも1つの慢性疾患を持つ50歳以上の個人数が、2020年の7,152万人から2050年には1億4,266万人へと99.5％増加すると予測されています。したがって、慢性疾患の蔓延がマルチプレックス・バイオマーカー・イメージング市場の拡大に拍車をかけています。

マルチプレックス・バイオマーカー・イメージング市場の主要企業は、自動スライドローダーなどの革新的ソリューションの提供に注力し、高度なイメージング機能を提供し、顧客体験を向上させています。自動スライドローダーは、サンプルハンドリングを合理化し、手作業を減らし、大量のマルチプレックス・バイオマーカー・イメージング実験を行う上で重要なスループットを向上させる。例えば、米国を拠点とする分析システムと機器のプロバイダーであるStandard BioTools Inc.は、2024年4月にHyperion XTi Imaging Systemを発表しました。このシステムは、自動化と柔軟性を加えた新しいハイスループット・マルチプレックス・ホールスライドを特徴としています。このシステムは、迅速分析のための3つのモード（プレビュー、組織、細胞モード）を備えており、研究者は組織の不均一性を迅速に可視化し、詳細な分析を行うことができます。imaging mass cytometry（IMC）を用いた新しいホールスライドイメージングアプローチは、周期的免疫蛍光イメージングと比較して最大10倍のスループットを提供します。さらに、自動スライドローダーの搭載により、ハイスループットのイメージングが合理化され、手作業が削減され、標準化が保証されます。これらの技術革新は、空間プロテオミクスにおけるブレークスルーを促進し、健康と疾患に関する信頼できる洞察を提供することを目的としています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、新型コロナウイルス感染症、そして景気回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界マルチプレックス・バイオマーカー・イメージング PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界のマルチプレックス・バイオマーカー・イメージング市場：成長率分析
• 世界のマルチプレックス・バイオマーカー・イメージング市場の実績：規模と成長, 2019-2024
• 世界のマルチプレックス・バイオマーカー・イメージング市場の予測：規模と成長, 2024-2029, 2034F
• 世界マルチプレックス・バイオマーカー・イメージング総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界のマルチプレックス・バイオマーカー・イメージング市場：コンポーネントタイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機器
• ソフトウェア
• サービス
• 世界のマルチプレックス・バイオマーカー・イメージング市場画像技術による、実績と予測, 2019-2024, 2024-2029F, 2034F
• 免疫蛍光（IF）アッセイ
• 組織マイクロアレイ（TMA）アッセイ
• 免疫組織化学（IHC）アッセイ
• 蛍光in the situハイブリダイゼーション（FISH）アッセイ
• トポノームイメージングシステム（TIS）
• 世界のマルチプレックス・バイオマーカー・イメージング市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 医薬品の安全性
• 腫瘍学研究
• 遺伝子特性研究
• 世界のマルチプレックス・バイオマーカー・イメージング市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 政府および民間の調査機関
• 臨床検査室
• 製薬およびバイオテクノロジー
• 世界のマルチプレックス・バイオマーカー・イメージング市場、楽器の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• イメージングシステム（顕微鏡、スキャナー）
• 検出装置（センサー、プローブ）
• 試薬とキット
• 世界のマルチプレックス・バイオマーカー・イメージング市場ソフトウェアの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 画像解析ソフトウェア
• データ管理ソフトウェア
• 視覚化および解釈ソフトウェア
• 世界のマルチプレックス・バイオマーカー・イメージング市場、サービスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 技術サポートとメンテナンス
• コンサルティングとトレーニング
• 画像解析サービス

第7章 地域別・国別分析

• 世界のマルチプレックス・バイオマーカー・イメージング市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界のマルチプレックス・バイオマーカー・イメージング市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• マルチプレックス・バイオマーカー・イメージング市場：競合情勢
• マルチプレックス・バイオマーカー・イメージング市場：企業プロファイル
  • Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Becton Dickinson and Company（BD）Overview, Products and Services, Strategy and Financial Analysis
  • Carl Zeiss AG Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Illumina Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Bio-Techne Corporation
• Leica Biosystems Nussloch GmbH
• Abcam Plc
• Meso Scale Diagnostics LLC
• Fluidigm Corporation
• NanoString Technologies
• Quanterix Corporation
• Akoya Biosciences
• Enzo Biochem Inc.
• Cisbio Bioassays
• Flagship Biosciences

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• マルチプレックス・バイオマーカー・イメージング市場2029：新たな機会を提供する国
• マルチプレックス・バイオマーカー・イメージング市場2029：新たな機会を提供するセグメント
• マルチプレックス・バイオマーカー・イメージング市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Multiplex biomarker imaging is a technique that enables the simultaneous detection and analysis of multiple biomarkers within a single sample. This approach allows for the visualization of complex biological processes and molecular profiles. Advanced imaging technologies are used to map the spatial distribution of biomarkers within tissues, providing detailed insights into cellular interactions and microenvironments.

The main components of multiplex biomarker imaging include instruments, software, and services. Instruments are tools or devices used for specific scientific tasks or for making measurements such as speed, height, or sound. Imaging techniques used in this context include immuno fluorescence (IF) assay, tissue microarray (TMA) assay, immunohistochemistry (IHC) assay, fluorescent in situ hybridization (FISH) assay, and toponome imaging system (TIS). These techniques find applications in areas such as drug safety, oncology studies, and genetic characterization studies. End users of multiplex biomarker imaging include research institutes (government and private), clinical labs, pharmaceutical companies, and biotechnology firms.

The multiplex biomarker imaging market research report is one of a series of new reports from The Business Research Company that provides multiplex biomarker imaging market statistics, including the multiplex biomarker imaging industry global market size, regional shares, competitors with the multiplex biomarker imaging market share, detailed multiplex biomarker imaging market segments, market trends, and opportunities, and any further data you may need to thrive in the multiplex biomarker imaging industry. These multiplex biomarker imaging market research reports deliver a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The multiplex biomarker imaging market size has grown rapidly in recent years. It will grow from $0.49 billion in 2024 to $0.54 billion in 2025 at a compound annual growth rate (CAGR) of 11.0%. The growth in the historic period can be attributed to the high incidence of cancer, the need for precise diagnostic tools, the growing prevalence of chronic diseases, the increase in the aging population, and the shift towards personalized medicine.

The multiplex biomarker imaging market size is expected to see rapid growth in the next few years. It will grow to $0.82 billion in 2029 at a compound annual growth rate (CAGR) of 10.8%. The growth in the forecast period can be attributed to increasing emphasis on personalized medicine, increased research and development activities, increasing clinical trials, the need for high throughput screening methods in drug discovery, and supportive regulatory frameworks and guidelines. Major trends in the forecast period include technological advancements, innovations in imaging technologies, advances in digital pathology, developments in data analysis and imaging software, and integration of AI and machine learning with imaging technologies.

The increasing prevalence of chronic diseases is expected to drive the growth of the multiplex biomarker imaging market in the coming years. Chronic diseases are enduring health conditions that persist or recur over time, often with complex origins, multiple risk factors, and extended latency periods. The rising prevalence of chronic diseases can be attributed to various factors, including the rapid aging of populations, improved disease detection methods, better disease treatment and management, and changes in lifestyle and environmental risk factors. Multiplex biomarker imaging plays a vital role in managing chronic diseases by enabling comprehensive analysis and characterization of disease progression and response to treatment. For instance, a report published by the National Institutes of Health (NIH) in January 2023 projected a 99.5% increase in the number of individuals aged 50 and older with at least one chronic illness, from 71.52 million in 2020 to 142.66 million in 2050. Hence, the growing prevalence of chronic diseases is fueling the expansion of the multiplex biomarker imaging market.

Major players in the multiplex biomarker imaging market are focusing on offering innovative solutions, such as automated slide loaders, to deliver advanced imaging capabilities and enhance customer experience. Automated slide loaders streamline sample handling, reducing manual effort and improving throughput, which is crucial for conducting high-volume multiplex biomarker imaging experiments. For example, Standard BioTools Inc., a US-based provider of analytical systems and instruments, introduced the Hyperion XTi Imaging System in April 2024, featuring a new high-throughput multiplexed whole slide with added automation and flexibility. This system offers three modes for rapid analysis-preview, tissue, and cell modes-enabling researchers to quickly visualize tissue heterogeneity and conduct in-depth analysis. The novel whole slide imaging approach using imaging mass cytometry (IMC) provides up to 10 times higher throughput compared to cyclic immunofluorescent imaging. Additionally, the inclusion of an automated slide loader streamlines high-throughput imaging, reducing manual effort and ensuring standardization. These innovations aim to expedite breakthroughs in spatial proteomics, providing reliable insights into health and disease.

In March 2024, Calyx, a UK-based provider of medical imaging services, merged with Invicro to create a global leader in medical imaging and software solutions. This merger brings together expertise in medical imaging and software to offer enhanced support to customers in the biopharma industry, ranging from large pharmaceutical companies to specialized biotech firms. The merger between Calyx and Invicro, a US-based next-generation quantitative imaging biomarker company, creates a differentiated industry leader and addresses growing customer needs for comprehensive support.

Major companies operating in the multiplex biomarker imaging market are Merck KGaA, Thermo Fisher Scientific Inc., Danaher corporation, Becton Dickinson and Company (BD), Carl Zeiss AG, Illumina Inc, PerkinElmer Inc., Bio-Rad Laboratories Inc, Bruker Corporation, Bio-Techne Corporation, Leica Biosystems Nussloch GmbH, Abcam Plc, Meso Scale Diagnostics LLC, Fluidigm Corporation, NanoString Technologies, Quanterix Corporation, Akoya Biosciences, Enzo Biochem Inc, Cisbio Bioassays, Flagship Biosciences, Aushon BioSystems Ltd, Ionpath Inc., Biosims Technologies

North America was the largest region in the multiplex biomarker imaging market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the multiplex biomarker imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the multiplex biomarker imaging market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The multiplex biomarker imaging market consists of revenues earned by entities by providing services such as imaging and analysis services, pathology services, and clinical and diagnostic services. The market value includes the value of related goods sold by the service provider or included within the service offering. The multiplex biomarker imaging market also includes sales of imaging instruments, reagents and kits, software, and analysis tools that are used in providing multiplex biomarker imaging services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Multiplex Biomarker Imaging Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on multiplex biomarker imaging market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for multiplex biomarker imaging ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The multiplex biomarker imaging market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Component Type: Instruments; Software; Services
• 2) By Imaging Techniques: Immuno Fluorescence (IF) Assay; Tissue Microarray (TMA) Assay; Immunohistochemistry (IHC) Assay; Fluorescent In The Situ Hybridization (FISH) Assay; Toponome Imaging System (TIS)
• 3) By Application: Drug Safety; Oncology Studies; Genetic Characterization Studies
• 4) By End User: Research Institutes Government And Private; Clinical Labs; Pharmaceutical And Biotechnology
• Subsegments:
• 1) By Instruments: Imaging Systems (Microscopes, Scanners); Detection Devices (Sensors, Probes); Reagents And Kits
• 2) By Software: Image Analysis Software; Data Management Software; Visualization And Interpretation Software
• 3) By Services: Technical Support And Maintenance; Consultation And Training; Imaging And Analysis Services
• Companies Mentioned: Merck KGaA; Thermo Fisher Scientific Inc.; Danaher corporation; Becton Dickinson and Company (BD); Carl Zeiss AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Multiplex Biomarker Imaging Market Characteristics

3. Multiplex Biomarker Imaging Market Trends And Strategies

4. Multiplex Biomarker Imaging Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Multiplex Biomarker Imaging Growth Analysis And Strategic Analysis Framework

• 5.1. Global Multiplex Biomarker Imaging PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Multiplex Biomarker Imaging Market Growth Rate Analysis
• 5.4. Global Multiplex Biomarker Imaging Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Multiplex Biomarker Imaging Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Multiplex Biomarker Imaging Total Addressable Market (TAM)

6. Multiplex Biomarker Imaging Market Segmentation

• 6.1. Global Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Instruments
• Software
• Services
• 6.2. Global Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Immuno Fluorescence (IF) Assay
• Tissue Microarray (TMA) Assay
• Immunohistochemistry (IHC) Assay
• Fluorescent In The Situ Hybridization (FISH) Assay
• Toponome Imaging System (TIS)
• 6.3. Global Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Safety
• Oncology Studies
• Genetic Characterization Studies
• 6.4. Global Multiplex Biomarker Imaging Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Research Institutes Government And Private
• Clinical Labs
• Pharmaceutical And Biotechnology
• 6.5. Global Multiplex Biomarker Imaging Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Imaging Systems (Microscopes, Scanners)
• Detection Devices (Sensors, Probes)
• Reagents And Kits
• 6.6. Global Multiplex Biomarker Imaging Market, Sub-Segmentation Of Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Image Analysis Software
• Data Management Software
• Visualization And Interpretation Software
• 6.7. Global Multiplex Biomarker Imaging Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Technical Support And Maintenance
• Consultation And Training
• Imaging And Analysis Services

7. Multiplex Biomarker Imaging Market Regional And Country Analysis

• 7.1. Global Multiplex Biomarker Imaging Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Multiplex Biomarker Imaging Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Multiplex Biomarker Imaging Market

• 8.1. Asia-Pacific Multiplex Biomarker Imaging Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Multiplex Biomarker Imaging Market

• 9.1. China Multiplex Biomarker Imaging Market Overview
• 9.2. China Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Multiplex Biomarker Imaging Market

• 10.1. India Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Multiplex Biomarker Imaging Market

• 11.1. Japan Multiplex Biomarker Imaging Market Overview
• 11.2. Japan Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Multiplex Biomarker Imaging Market

• 12.1. Australia Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Multiplex Biomarker Imaging Market

• 13.1. Indonesia Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Multiplex Biomarker Imaging Market

• 14.1. South Korea Multiplex Biomarker Imaging Market Overview
• 14.2. South Korea Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Multiplex Biomarker Imaging Market

• 15.1. Western Europe Multiplex Biomarker Imaging Market Overview
• 15.2. Western Europe Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Multiplex Biomarker Imaging Market

• 16.1. UK Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Multiplex Biomarker Imaging Market

• 17.1. Germany Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Multiplex Biomarker Imaging Market

• 18.1. France Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Multiplex Biomarker Imaging Market

• 19.1. Italy Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Multiplex Biomarker Imaging Market

• 20.1. Spain Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Multiplex Biomarker Imaging Market

• 21.1. Eastern Europe Multiplex Biomarker Imaging Market Overview
• 21.2. Eastern Europe Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Multiplex Biomarker Imaging Market

• 22.1. Russia Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Multiplex Biomarker Imaging Market

• 23.1. North America Multiplex Biomarker Imaging Market Overview
• 23.2. North America Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Multiplex Biomarker Imaging Market

• 24.1. USA Multiplex Biomarker Imaging Market Overview
• 24.2. USA Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Multiplex Biomarker Imaging Market

• 25.1. Canada Multiplex Biomarker Imaging Market Overview
• 25.2. Canada Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Multiplex Biomarker Imaging Market

• 26.1. South America Multiplex Biomarker Imaging Market Overview
• 26.2. South America Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Multiplex Biomarker Imaging Market

• 27.1. Brazil Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Multiplex Biomarker Imaging Market

• 28.1. Middle East Multiplex Biomarker Imaging Market Overview
• 28.2. Middle East Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Multiplex Biomarker Imaging Market

• 29.1. Africa Multiplex Biomarker Imaging Market Overview
• 29.2. Africa Multiplex Biomarker Imaging Market, Segmentation By Component Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Multiplex Biomarker Imaging Market, Segmentation By Imaging Techniques, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Multiplex Biomarker Imaging Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Multiplex Biomarker Imaging Market Competitive Landscape And Company Profiles

• 30.1. Multiplex Biomarker Imaging Market Competitive Landscape
• 30.2. Multiplex Biomarker Imaging Market Company Profiles
  • 30.2.1. Merck KGaA Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Becton Dickinson and Company (BD) Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Carl Zeiss AG Overview, Products and Services, Strategy and Financial Analysis

31. Multiplex Biomarker Imaging Market Other Major And Innovative Companies

• 31.1. Illumina Inc.
• 31.2. PerkinElmer Inc.
• 31.3. Bio-Rad Laboratories Inc.
• 31.4. Bruker Corporation
• 31.5. Bio-Techne Corporation
• 31.6. Leica Biosystems Nussloch GmbH
• 31.7. Abcam Plc
• 31.8. Meso Scale Diagnostics LLC
• 31.9. Fluidigm Corporation
• 31.10. NanoString Technologies
• 31.11. Quanterix Corporation
• 31.12. Akoya Biosciences
• 31.13. Enzo Biochem Inc.
• 31.14. Cisbio Bioassays
• 31.15. Flagship Biosciences

32. Global Multiplex Biomarker Imaging Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Multiplex Biomarker Imaging Market

34. Recent Developments In The Multiplex Biomarker Imaging Market

35. Multiplex Biomarker Imaging Market High Potential Countries, Segments and Strategies

• 35.1 Multiplex Biomarker Imaging Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Multiplex Biomarker Imaging Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Multiplex Biomarker Imaging Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer